Tumor Protein, Translationally-Controlled 1 [translačně kontrolovaný nádorový protein 1]
- Terms
-
faktor uvolňující histamin
protein P23, Ehrlichův ascitický nádor
protein TPT1
-
Histamine Releasing Factor
Histamine Releasing Factor, Lymphocyte-Dependent
Histamine-Releasing Factor (IgE-Dependent)
Protein P23, Ehrlich Ascites Tumor
TPT1 Protein
Translationally-Controlled Tumor Protein
A highly expressed protein in tumor cells, encoded by Tpt1 gene. It's involved in various cellular activities including protein synthesis, calcium-binding, MICROTUBULE stabilization, growth, and cell survival. Also, Tpt1 identified as a direct target gene of P53 tumor suppression.
- DUI
- D000090324 MeSH Browser
- CUI
- M0132475
- History note
- 2022 (1985)
- Public note
- 2022; TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1 was indexed under BIOMARKERS, TUMOR 1987-2021; under CALCIUM-BINDING PROTEINS 1997-2002; under GROWTH SUBSTANCES 1995-2002; under LYMPHOKINES 1985-2002; and under NEOPLASM PROTEINS 1994-2002
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0